drugset

drugset / Trial / NCT02784847

A Pilot Trial of Triheptanoin for the Preventive Treatment of Migraine

NCT02784847 ↗

Phase 0 Unknown 10 enrolled University of Liege

NaSingle-groupOpen-labelTreatment

Summary

A pilot trial of triheptanoin, a natural compound able to promote anaplerotic mitochondrial metabolism, for the preventative treatment of migraine.

Timeline

Start: 2016-06
Primary completion: 2016-11
Completion: 2016-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Triheptanoin	Other / unclassified	1 mg/kg	—

Indications